Research Paper Volume 14, Issue 9 pp 4107—4136
RecQ mediated genome instability 2 (RMI2): a potential prognostic and immunological biomarker for pan-cancers
Figure 1. The differential expression of RMI2 gene in human tumors. (A) The expression of RMI2 in different cancers and paired normal tissue in the Oncomine database. (B) The RMI2 expression levels in different cancer types from the TCGA database analyzed by the TIMER database. ((″***″ indicates P<0.001, ″**″ indicates P<0.01 and ″*″ indicates P<0.05). (C) The RMI2 expression in several cancers and adjacent paired normal tissue in the GEPIA database.